INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio update as at 31 July 2010
Total Net Assets |
£96.3m |
NAV per share |
159.6p |
Share Price |
136.8p |
Total value of unquoted investments |
£22.7m |
Total number of portfolio companies |
60 |
Cash |
4% |
Cash committed and reserved to unquoted investments |
12% |
Portfolio companies with < 1 year of cash |
8% |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
6.00 |
Micromet |
5.66 |
Amgen |
5.63 |
Genzyme |
5.35 |
Shire |
5.15 |
Alexion Pharmaceuticals |
4.13 |
Gilead Sciences |
3.30 |
EUSA Pharma |
3.11 |
Oxagen |
3.02 |
Insulet Corp |
2.82 |
|
----------- |
Total |
42.52 |
Geographical Allocation |
% |
United States |
75 |
Europe |
19 |
Cash |
4 |
Australia |
2 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
73 |
Unquoted |
23 |
Cash |
4 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
18 AUGUST 2010